4.7 Article

Exploring IDP-Ligand Interactions: Tau K18 as a Test Case

Journal

Publisher

MDPI
DOI: 10.3390/ijms21155257

Keywords

intrinsically disordered protein; tau K18; nuclear magnetic resonance; surface plasmon resonance; microscale thermophoresis

Funding

  1. European Union's Framework Programme for Research and Innovation Horizon 2020 (2014-2020) under the Marie Sklodowska-Curie grant [675899]

Ask authors/readers for more resources

Over the past decade intrinsically disordered proteins (IDPs) have emerged as a biologically important class of proteins, many of which are of therapeutic relevance. Here, we investigated the interactions between a model IDP system, tau K18, and nine literature compounds that have been reported as having an effect on tau in order to identify a robust IDP-ligand system for the optimization of a range of biophysical methods. We used NMR, surface plasmon resonance (SPR) and microscale thermophoresis (MST) methods to investigate the binding of these compounds to tau K18; only one showed unambiguous interaction with tau K18. Several near neighbors of this compound were synthesized and their interactions with tau K18 characterized using additional NMR methods, including 1D ligand-observed NMR, diffusion-ordered spectroscopy (DOSY) and(19)F NMR. This study demonstrates that it is possible to detect and characterize IDP-ligand interactions using biophysical methods. However, care must be taken to account for possible artefacts, particularly the impact of compound solubility and where the protein has to be immobilized.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Modelling the binding mode of macrocycles: Docking and conformational sampling

Sarah J. Martin, I-Jen Chen, A. W. Edith Chan, Nicolas Foloppe

BIOORGANIC & MEDICINAL CHEMISTRY (2020)

Article Biochemistry & Molecular Biology

Two-dimensional NMR lineshape analysis of single, multiple, zero and double quantum correlation experiments

Christopher A. Waudby, Margaux Ouvry, Ben Davis, John Christodoulou

JOURNAL OF BIOMOLECULAR NMR (2020)

Article Chemistry, Multidisciplinary

Design and Synthesis of 56 Shape-Diverse 3D Fragments

Thomas D. Downes, S. Paul Jones, Hanna F. Klein, Mary C. Wheldon, Masakazu Atobe, Paul S. Bond, James D. Firth, Ngai S. Chan, Laura Waddelove, Roderick E. Hubbard, David C. Blakemore, Claudia De Fusco, Stephen D. Roughley, Lewis R. Vidler, Maria Ann Whatton, Alison J. -A. Woolford, Gail L. Wrigley, Peter O'Brien

CHEMISTRY-A EUROPEAN JOURNAL (2020)

Article Chemistry, Multidisciplinary

Rapid optimisation of fragments and hits to lead compounds from screening of crude reaction mixtures

Lisa M. Baker, Anthony Aimon, James B. Murray, Allan E. Surgenor, Natalia Matassova, Stephen D. Roughley, Patrick M. Collins, Tobias Krojer, Frank von Delft, Roderick E. Hubbard

COMMUNICATIONS CHEMISTRY (2020)

Article Biochemistry & Molecular Biology

Fragment-derived modulators of an industrial β-glucosidase

Eleni Makraki, John F. Darby, Marta G. Carneiro, James D. Firth, Alex Heyam, A. B. Eiso, Peter O'Brien, Gregg Siegal, Roderick E. Hubbard

BIOCHEMICAL JOURNAL (2020)

Article Chemistry, Medicinal

Design and Synthesis of Pyrrolo[2,3-d]pyrimidine-Derived Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Checkpoint Kinase 1 (CHK1)-Derived Crystallographic Surrogate

Douglas S. Williamson, Garrick P. Smith, Gitte K. Mikkelsen, Thomas Jensen, Pamela Acheson-Dossang, Lassina Badolo, Simon T. Bedford, Victoria Chell, I-Jen Chen, Pawel Dokurno, Morten Hentzer, Samantha Newland, Stuart C. Ray, Terry Shaw, Allan E. Surgenor, Lindsey Terry, Yikang Wang, Kenneth Christensen

Summary: In this study, inhibitors of LRRK2 and mutants were optimized based on the X-ray structures of LRRK2 kinase domain surrogates. The resulting compounds showed increased potency and selectivity for LRRK2, making them useful as chemical probes for studying LRRK2 inhibition in Parkinson's disease treatment.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

A covalent strategy to target intrinsically disordered proteins: Discovery of novel tau aggregation inhibitors

Laszlo Petri, Peter Abranyi-Balogh, Darius Vagrys, Timea Imre, Nikolett Varro, Istvan Mandity, Anita Racz, Lucia Wittner, Kinga Toth, Estilla Zsofia Toth, Tunde Juhasz, Ben Davis, Gyoergy Miklos Keseru

Summary: In this study, a covalent design strategy targeting intrinsically disordered proteins (IDPs) was developed based on the promising results of targeted covalent inhibitors (TCIs) on challenging targets. Using tau protein as a model system, suitable warheads were introduced to non-covalent scaffolds of potential tau aggregation inhibitors. The designed covalent tau binders effectively inhibited tau aggregation in aggregation models, providing promising candidates for the treatment of tauopathies.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Chemistry, Medicinal

Fragment Merging Using a Graph Database Samples Different Catalogue Space than Similarity Search

Stephanie Wills, Ruben Sanchez-Garcia, Tim Dudgeon, Stephen D. Roughley, Andy Merritt, Roderick E. Hubbard, James Davidson, Frank von Delft, Charlotte M. Deane

Summary: Fragment merging is a promising approach to advancing fragments directly to on-scale potency. Searching commercial catalogues allows for quick and cost-effective identification of these merges, circumventing the challenge of synthetic accessibility.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2023)

Article Biochemistry & Molecular Biology

Exploration of piperidine 3D fragment chemical space: synthesis and 3D shape analysis of fragments derived from 20 regio- and diastereoisomers of methyl substituted pipecolinates

S. Paul Jones, James D. Firth, Mary C. Wheldon, Masakazu Atobe, Roderick E. Hubbard, David C. Blakemore, Claudia De Fusco, Simon C. C. Lucas, Stephen D. Roughley, Lewis R. Vidler, Maria Ann Whatton, Alison J-A Woolford, Gail L. Wrigley, Peter O'Brien

Summary: This study reports the synthesis of piperidine-based 3D fragment building blocks and demonstrates their suitability for fragment-based drug discovery programs.

RSC MEDICINAL CHEMISTRY (2022)

Article Chemistry, Medicinal

Discovery of S64315, a Potent and Selective Mcl-1 Inhibitor

Zoltan Szlavik, Marton Csekei, Attila Paczal, Zoltan B. Szabo, Szabolcs Sipos, Gabor Radics, Agnes Proszenyak, Balazs Balint, James Murray, James Davidson, Ijen Chen, Pawel Dokurno, Allan E. Surgenor, Zoe Marie Daniels, Roderick E. Hubbard, Gaetane Le Toumelin-Braizat, Audrey Claperon, Gaelle Lysiak-Auvity, Anne-Marie Girard, Alain Bruno, Maia Chanrion, Frederic Colland, Ana-Leticia Maragno, Didier Demarles, Olivier Geneste, Andras Kotschy

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Biochemistry & Molecular Biology

Protein-fragment complex structures derived by NMR molecular replacement

Felix Torres, Dhiman Ghosh, Dean Strotz, Celestine N. Chi, Ben Davis, Julien Orts

RSC MEDICINAL CHEMISTRY (2020)

No Data Available